153
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Journal

A novel GRK1 mutation in an Italian patient with Oguchi disease

, , , , , , & show all

References

  • Mizuo G. On a new discovery in the dark adaptation on Oguchi’s disease. Acta Soc Ophthalmol Jpn 1913;17:1148.
  • Heckenlively JR, Weleber RG. X-linked recessive cone dystrophy with tapetal-like sheen. A newly recognized entity with Mizuo–Nakamura phenomenon. Arch Ophthalmol 1986 Sep;104(9):1322–1328.
  • De Jong PT, Zrenner E, Van Meel GJ, et al. Mizuo phenomenon in X-linked retinoschisis. Pathogenesis of the Mizuo phenomenon. Arch Ophthalmol 1991 Aug;109(8):1104–1108.
  • Godara P, Cooper RF, Sergouniotis PI, et al. Assessing retinal structure in complete congenital stationary night blindness and Oguchi disease. Am J Ophthalmol 2012 Dec;154(6):987–1001.e1.
  • Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am J Ophthalmol 2000;130:547–563.
  • Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863–74.
  • Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
  • Sonoyama H, Shinoda K, Ishigami C, et al. Oguchi disease masked by retinitis pigmentosa. Doc Ophthalmol 2011 Oct;123(2):127–133.
  • Nakazawa M, Wada Y, Tamai M. Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Arch Ophthalmol 1998 Apr;116(4):498–501.
  • Yamanaka M. Histologic study of Oguchi’s disease. Its relationship to pigmentary degeneration of the retina. Am J Ophthalmol 1969 Jul;68(1):19–26.
  • Khan KN, Mahroo OA, Khan RS, et al. Differentiating drusen: drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes. Prog Retin Eye Res 2016 Jul;53:70–106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.